biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Ignore the chirps...repeat...

<< Previous

Bullboard Posts

Next >>

Post by OysterBuctoucheon Apr 28, 2021 8:59am

189 Views

Post# 33081180

Ignore the chirps...repeat...

As usual the chirps continue with exact same theme and ignorance. Hang in there Chrispi and JD -try to ignore. Bioasis has a very qualified and hard working CEO and is surrounded by very high level intelligence and background on the Board. They will stay the course and this will play out nicely. Yes been a long bumpy road but never been a better time with a low SP to continue to lay the bets. There will be a day the chirpers will be silenced by the success of the Bioasis science. And that will feel better than getting free and clear of blackfly season.

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide